TheEdgeResearch
Home / Stocks / MCVEY

Medicover AB (publ) (MCVEY)

OTC Healthcare Medical - Care Facilities
$16.55 ▲ +0.00%
Market Cap
$2.52B
Sector
Healthcare
Industry
Medical - Care Facilities
Beta
1.59
52-Wk Range
16.55-21.54
CEO
John Paul Stubbington
Country
SE
Currency
USD

Medicover AB (publ) operates in the Medical - Care Facilities industry of the Healthcare sector, headquartered in Stockholm, AB, SE. The stock last traded at $16.55, up 0.00% on the session, giving a market capitalisation of $2.52B. On trailing twelve-month figures it carries a trailing P/E of 38.75, a net margin of 3.7%. Its beta of 1.59 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
38.75
Price / Sales
1.42
Price / Book
6.44
EV / EBITDA
11.66
Gross margin
23.7%
Operating margin
7.5%
Net margin
3.7%
Return on equity
—
Debt / equity
2.34
Current ratio
0.75
Dividend yield
0.9%
Payout ratio
33.2%
Company profile
Exchange
Other OTC
Employees
49,000
IPO date
2019-03-22
Headquarters
Stockholm, AB, SE
About Medicover AB (publ)

Established in 1995 and headquartered in Stockholm, Sweden, Medicover AB (publ) is a prominent international provider of both healthcare and diagnostic services. The company operates across numerous countries, including Germany, Sweden, Poland, Turkey, Belarus, Bulgaria, Georgia, Hungary, Serbia, Moldova, Ukraine, and India. It is structured into two main divisions: Healthcare Services and Diagnostic Services. Through its diagnostic division, Medicover performs a comprehensive array of specialized tests, which include analyses for allergy and autoimmune conditions; bacteriology and parasitology; biochemistry and immunochemistry; blood group diagnostics and transfusion medicine; tumour markers; clinical chemistry; cellular analyses like cytology, haematology, and histopathology; human genetics; hygiene; general immunology; infectious diseases; microbiology; molecular biology; and pharmacology/toxicology. Medicover maintains a substantial operational footprint, encompassing 97 clinical laboratories, 733 blood-drawing points, and 26 clinics dedicated to diagnostic services across 10 countries. Its healthcare segment further comprises 117 medical clinics, 20 fertility clinics, 52 dental clinics, 25 hospitals, and 25 gyms. The company caters to a broad customer base, serving corporate entities, private individuals, direct patients, and public sector payers.

Comparable companies

Medicover AB (publ) is most often compared with the following Healthcare names:

ARDTASTHDGXLTGHYMDNUTXNWKHYSKHHYTHCUHS
More research on MCVEY
MCVEY technical analysis MCVEY TheEdge Score Compare against peers
Open full interactive analysis & DCF →